Global Health Collaborative Uganda
  • Home
  • Who We Are
    • Our Mission
    • Our History
    • MUST & MRRH Leadership
    • MUST-MGH Global Health staff
    • Our Partners
  • Our Work
    • Research & Innovation
      • Health Families
      • META
      • OpenSMS
      • REVAMP
      • SASH
      • SBI
      • UPIM
      • Extend
    • Global Partnerships
    • Core Infrastructure
  • Events
  • Stories from the field
    • combatting barriers to care in rural uganda
    • national nursing conference in uganda
    • out-of-the-box solutions for HIV/AIDS treatment in uganda
    • studying the barriers to antimalarial bednet use in uganda
  • Visitors
    • visitor information
    • visitor FAQ
  • Contact Us
 

Measuring Early HIV Treatment Adherence


The study main objective is to “Examine Early HIV Treatment Adherence in different populations”. Specifically, looking on how people with high CD4 count (>350) adhere compared to people who have low CD4 count (<200) and how pregnant women adhere compared to non- pregnant women. Participants are monitored for 12 months using an electronic monitoring wireless adherence device (wisepill). META has two sites in Uganda; Mbarara and Kabwohe.

Principle Investigators: Dr. Jessica Harberer (MGH) and Dr. Bosco Bwana Mwebesa (MUST)

GHC Facebook

↑
Forum